Gastroenterology, Hepatology & Digestive Disorders最新文献

筛选
英文 中文
Tenofovir Induced Hepatitis B Surface Antigen Loss and Seroconversion in Two Patients with E-Antigen Negative Chronic Hepatitis B Infection: Case Series 替诺福韦诱导两例e抗原阴性慢性乙型肝炎感染患者乙型肝炎表面抗原丢失和血清转化:病例系列
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-12-31 DOI: 10.33425/2639-9334.1069
Ijarotimi O, Betiku O.A, Osasona E.O, Umenze I, Adekanle O, Ndububa D.A
{"title":"Tenofovir Induced Hepatitis B Surface Antigen Loss and Seroconversion in Two Patients with E-Antigen Negative Chronic Hepatitis B Infection: Case Series","authors":"Ijarotimi O, Betiku O.A, Osasona E.O, Umenze I, Adekanle O, Ndububa D.A","doi":"10.33425/2639-9334.1069","DOIUrl":"https://doi.org/10.33425/2639-9334.1069","url":null,"abstract":"Two cases of HBsAg seroconversion, following treatment with Tenofovir disoproxil fumarate, a nucleotide reverse transcriptase inhibitor, were reported amongst the patients with chronic hepatitis B infection attending gastrointestinal clinic in a tertiary hospital. The patients had liver biopsy done during their evaluation, following which they were commenced on the medication. Tenofovir was taken for four years and two years respectively before they lost the hepatitis B surface antigen and developed quantifiable antibodies to the surface antigen (Anti-HBs). Loss of HBsAg is a rare event, and seroconversion in patients with CHB is even less common. Studies have shown that HBsAg loss and seroconversion is less likely with patients on the oral antiviral agents compared with pegylated interferon. Although, both patients had very low pretreatment hepatitis B viral load which might indicate strong immune response to the virus, a factor that could have been partly responsible for the seroconversion. They however, had significant liver fibrosis on histology prior to their seroconversion and will require hepatocellular cancer surveillance until normalization of the liver histology can be ascertained.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133496177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Correlation Study of Liver Biopsy Appearances, Serum HBV DNA and HBsAg Quantification Levels of Nigerian Patients with Chronic Liver Disease 尼日利亚慢性肝病患者肝活检表现与血清HBV DNA和HBsAg定量水平的相关性研究
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-12-31 DOI: 10.33425/2639-9334.1070
O. Betiku, O. Adekanle, D. Ndububa, O. Ojo
{"title":"A Correlation Study of Liver Biopsy Appearances, Serum HBV DNA and HBsAg Quantification Levels of Nigerian Patients with Chronic Liver Disease","authors":"O. Betiku, O. Adekanle, D. Ndububa, O. Ojo","doi":"10.33425/2639-9334.1070","DOIUrl":"https://doi.org/10.33425/2639-9334.1070","url":null,"abstract":"Background: Infection with the hepatitis B virus is highly endemic in much of sub-Saharan Africa where it remains an important cause of chronic ill-health. Quantitative assay of HBV DNA and HBsAg are emerging as useful tools in the management of chronic HBV infection. However, it is not yet clear how well each of these might accurately correlate with the extent of liver damage during the course of the disease. Nevertheless, liver biopsy, albeit an invasive test, affords a superior direct assessment of all stages of the disease. Objective: Thus, we set out to determine how well-correlated serum levels of HBV-DNA and/or HBsAg might be with each other and with the liver biopsy appearances. Methodology: This study was prospective and we enrolled, 83 new treatment-naïve patients, who met the study criteria. Each patient had liver biopsy assessments of the grade of necroinflammation (A) and stage of fibrosis (F), according to the METAVIR Scoring System. In addition, quantitative HBsAg serum levels by immunoassay and HBV DNA by real-time quantitative PCR protocols were made. The Spearman’s and Kruskal-Wallis statistical tests were employed to determine the correlations between these assays separately and with the respective histological grades and stages of liver biopsy. (p=0.05) Results: The greatest number of the patients were within the 21-40 year- age group. Using the Spearman rho’s statistical correlation test, we found a positive but weak correlation between the serum HBsAg and HBVDNA levels (p=0.075, r=0.198). The Kruskal-Wallis analysis revealed statistically significant correlation between HBV-DNA and the grade of necroinflammation but not with the stage of fibrosis. Conclusions: We found that the serum HBV DNA levels had the only statistically significant correlation with the liver histological disease. This relationship needs to be further examined in larger studies in the future.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123589139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2-Related Multisystem Inflammatory Syndrome in an Immunocompromised Child with Osteosarcoma Revealed by Hepatocellular Failure 肝细胞衰竭揭示免疫功能低下儿童骨肉瘤与sars - cov -2相关的多系统炎症综合征
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-12-31 DOI: 10.33425/2639-9334.1068
Ryouni K, Chahid I, Atrassi M, Bensabbahia D, Abkari A
{"title":"SARS-CoV-2-Related Multisystem Inflammatory Syndrome in an Immunocompromised Child with Osteosarcoma Revealed by Hepatocellular Failure","authors":"Ryouni K, Chahid I, Atrassi M, Bensabbahia D, Abkari A","doi":"10.33425/2639-9334.1068","DOIUrl":"https://doi.org/10.33425/2639-9334.1068","url":null,"abstract":"Introduction: Multisystem Inflammatory Syndrome in Children (MIS-C) is a new phenomenon reported worldwide with temporal association with COVID-19. Objective: The aim of our case report is to clarify the manifestations of a pims syndrome in a osteosarcoma field, which can be confused with metastases. Patients and methods: We report a case of a 12-year-old male patient followed for osteosarcoma of the right humerus who was admitted for hepatocellular failure with cutaneous-mucosal jaundice revealing a PIMS syndrome. Results: The patient had initially received 3 courses of chemotherapy, followed by monobloc resection of the tumour mass and osteosynthesis, who met the case definition of PIMS-TS presented with fever, multi organ and mucocutaneous involvement, cardiovascular and gastrointestinal symptoms. His biological work-up showed a significant inflammatory syndrome with very high ferritin levels, high D-dimer and pro-BNP levels, associated with lymphopenia and liver cytolysis. An echocardiogram revealed a dilated cardiomyopathy with an LVEF of 13% associated with a moderate pericardial effusion. The work-up was completed by a PCR covid which came back negative, when the serology came back positive confirming a PIMS-TS. Therapeutically, he received a course of immunoglobulin, corticosteroid, and in view of the myocardial damage, he was put on Aspirin, ACE inhibitor, beta-blocker and spironolactone after normalization of his blood pressure. The evolution was spectacular, marked by a clear clinical improvement, the normalisation of biological parameters and the improvement of his LVEF on echocardiography. Conclusion: Although the pathogenesis is not clearly known, immune-mediated injury has been implicated. We herein provide current information on this condition, in order to raise awareness amongst pediatricians.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116317176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Stool Antigen Test in patients infected by Helicobacter pylori after Eradication Therapy 幽门螺杆菌根除治疗后粪便抗原检测的评价
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-12-31 DOI: 10.33425/2639-9334.1067
P. Tahir
{"title":"Evaluation of Stool Antigen Test in patients infected by Helicobacter pylori after Eradication Therapy","authors":"P. Tahir","doi":"10.33425/2639-9334.1067","DOIUrl":"https://doi.org/10.33425/2639-9334.1067","url":null,"abstract":"Noninvasive tests for Helicobacter pylori are important in primary care, both for initial diagnosis of H. pylori infection and for confirmation of eradication. The objective of the present study was to evaluate the effectiveness of a stool antigen test after therapy. We studied 30 patients (16 males & 14 females) infected with H. pylori at the outpatient clinic in Azady teaching hospital. After the completion of triple eradication therapy, all patients were subjected to the examination of the stool antigen test. Of the total 30 cases, there were 23 cases with negative stool Ag test after therapy. All seven cases without therapy were positive stool, Ag. The result of the stool antigen test after therapy was 76% (negative in 23 patients, false-negative in 7 patients). We concluded that a negative result on stool antigen testing after completion of therapy recognizes patients in whom the eradication of H. pylori was successful.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114662125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Esophago-Gastric Anastomotic Leak with Endoscopic Vacuum Therapy- A Case Report and Review of Literature 内镜下真空治疗食管胃吻合口瘘1例并文献复习
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1066
Lad Sneha, Pawar Apoorva, K. Vishakha, Koppikar Mohan, B. Suryaprakash, P. Sitaram, Patankar Roy
{"title":"Management of Esophago-Gastric Anastomotic Leak with Endoscopic Vacuum Therapy- A Case Report and Review of Literature","authors":"Lad Sneha, Pawar Apoorva, K. Vishakha, Koppikar Mohan, B. Suryaprakash, P. Sitaram, Patankar Roy","doi":"10.33425/2639-9334.1066","DOIUrl":"https://doi.org/10.33425/2639-9334.1066","url":null,"abstract":"Transmural defects of the upper gastrointestinal (UGI) tract can be either leaks, perforations or fistulae. Endoscopic vac is a good option for management for localized leaks where stent placement is not feasible. We present a case of a 31-year-old lady who was operated for strangulated Bochdalek hernia with partial gastrectomy with esophago-gastric anastomosis. She then underwent 2 sittings of endo vac placement for management of an anastomotic leak with mediastinitis. She was followed up on outpatient basis with imaging and interval endoscopies. Post 6 months of the procedure, patient is well and is on full oral feeds.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126503227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors to Consider for Successful Telemedicine Gastroenterology Subspecialty Visits in Disparate Populations 在不同人群中成功进行远程医疗胃肠病学亚专科就诊的考虑因素
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1065
Hamid Ullah, L. Burstiner, Lucas B. Buchanan, S. Iqbal, A. Royer, Sarah Glover, Pegah Hosseini-Carroll
{"title":"Factors to Consider for Successful Telemedicine Gastroenterology Subspecialty Visits in Disparate Populations","authors":"Hamid Ullah, L. Burstiner, Lucas B. Buchanan, S. Iqbal, A. Royer, Sarah Glover, Pegah Hosseini-Carroll","doi":"10.33425/2639-9334.1065","DOIUrl":"https://doi.org/10.33425/2639-9334.1065","url":null,"abstract":"Introduction: Telemedicine was put at the forefront of the healthcare delivery process during the coronavirus disease 2019 (COVID-19) pandemic. Pre-COVID-19 research had shown telemedicine to be beneficial in the gastroenterology field with improved quality of life and reduced healthcare cost in the IBD population. However, telemedicine remained underutilized in subspecialty care with constraints at both provider and patient level. Objective: To analyze the telemedicine encounters in a gastroenterology clinic at a tertiary care hospital and identify factors that facilitate or limit the use of telemedicine modalities. Methods: The project was a retrospective, single-center study with continuous sampling of one hundred and fifty-three patients who scheduled one hundred and fifty-eight telemedicine encounters that included both Inflammatory Bowel Disease (IBD) and general gastroenterology patients. We examined the influence of age, sex, race, geographic location and payer source, on audio or video telemedicine encounters, as well as the show rate. Results: Our study showed a promising show rate of 90.5% with a majority of the patients preferring video over audio visits; however, increasing age proved to be a barrier in successfully completing video visits. In total, 26.2% of the patients who desired video encounters had to be switched to audio only. We found that race, sex, payor source, and living in a rural zip code did not influence the rate of completed telemedicine encounters or the patients’ preferred modality (audio vs video). Conclusion: The recurring COVID-19 surge due to different variants provides an opportunity to refine the telemedicine experience in our healthcare. Telemedicine encounters have a promising role in gastroenterology outpatient care and can be utilized to improve access to care and bridge healthcare disparities. In order to increase compliance further work needs to be done to make the digital platform user friendly for the elderly population.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"226 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132685009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric Cancer and QIAPI, Case Report 胃癌与QIAPI病例报告
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1061
A. Herrera, Nicolas Saavedra Rojas
{"title":"Gastric Cancer and QIAPI, Case Report","authors":"A. Herrera, Nicolas Saavedra Rojas","doi":"10.33425/2639-9334.1061","DOIUrl":"https://doi.org/10.33425/2639-9334.1061","url":null,"abstract":"Despite significant therapeutic progress, gastric cancer remains among the deadliest forms of cancer encountered in clinical practice, and this remains true even in the context of declining incidence. Outcomes in advanced disease remain poor and therapy is rarely curative in this setting. Different therapies have developed in the hopes of altering nearly uniformly poor outcomes.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology & Digestive Disorders","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127420729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Predictors of Cannabis Use Disorder among Inflammatory Bowel Disease Hospitalizations in the United States and its Effect on Length of Stay 美国炎症性肠病住院患者中大麻使用障碍的患病率和预测因素及其对住院时间的影响
Gastroenterology, Hepatology & Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1063
Y. Wang
{"title":"Prevalence and Predictors of Cannabis Use Disorder among Inflammatory Bowel Disease Hospitalizations in the United States and its Effect on Length of Stay","authors":"Y. Wang","doi":"10.33425/2639-9334.1063","DOIUrl":"https://doi.org/10.33425/2639-9334.1063","url":null,"abstract":"Background: The prevalence of cannabis use has been increasing in the United States in recent years. We examined the prevalence and predictors of cannabis use disorder among IBD hospitalizations and its effect on length of stay. Methods: Using the 2017 National Inpatient Sample, cannabis use disorder was identified using ICD-10-CM code F12.xxx in adult IBD patients. Other variables of interest included age, sex, race, Crohn’s disease (vs. ulcerative colitis), region, metropolitan status, zip code household income, primary insurance, and length of stay. Multivariate logistic and Poisson regressions were used in statistical analysis. Results: Of the 17,857 IBD hospitalizations, 565 (3.1%) had cannabis use disorder. Patients with cannabis use disorder were younger (mean ± standard deviation [years]: 35.1 ± 11.8 vs. 45.6 ± 18.1), less likely female (32.7% vs. 54.1%), more likely African American (24.8% vs. 13.9%), and more likely Crohn’s disease (72.0% vs. 62.2%) (all p<0.001). There were also significant differences by region, income, and insurance. Multivariate logistic regression confirmed age (odds ratio [95% confidence interval]: 0.964 [0.957, 0.971]), female (0.444 [0.369, 0.531]), African American (1.405 [1.124, 1.750]), and Crohn’s disease (1.363 [1.126, 1.657]) as predictors of cannabis use disorder. There was no association between cannabis use disorder and length of stay, confirmed in multivariate Poisson regression. Conclusions: Young age, male sex, African American race, and Crohn’s disease were positively associated with cannabis use disorder in IBD hospitalizations. There was no effect of cannabis use disorder on length of stay.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology &amp; Digestive Disorders","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126367057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual Dysfunction In Cirrhosis: A Prospective Multicenter Study 肝硬化患者的性功能障碍:一项前瞻性多中心研究
Gastroenterology, Hepatology &amp; Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1064
M. Guèye, Melissa C. E Sengue, S. Diallo, Djimby Sow, M. P. Fall, Cheikh Ahmadou Bamba Cissé, G. Diouf, M. Thioubou, Mame Coumba Cissé, M. Evra, M. L. Basséne, D. Dia, M. Mbengue
{"title":"Sexual Dysfunction In Cirrhosis: A Prospective Multicenter Study","authors":"M. Guèye, Melissa C. E Sengue, S. Diallo, Djimby Sow, M. P. Fall, Cheikh Ahmadou Bamba Cissé, G. Diouf, M. Thioubou, Mame Coumba Cissé, M. Evra, M. L. Basséne, D. Dia, M. Mbengue","doi":"10.33425/2639-9334.1064","DOIUrl":"https://doi.org/10.33425/2639-9334.1064","url":null,"abstract":"Introduction: All the manifestations of cirrhosis, sexual dysfunction, mainly because of its taboo nature. The least sought after by hepatologists and the least reported spontaneously by patients. Taking this condition into account is a necessity to improve the quality of life of patients. Methods: We conducted a prospective descriptive and analytical study over 14 months from March 2020 to April 2021 in patients followed for cirrhosis. Recruitment was multicenter. We included all cirrhotic patients who gave their consent to participate in the study. The diagnosis of cirrhosis was made on the basis of clinical, biological, radiological, endoscopic and histological evidence. The classification used was the simplified ASEX classification. Each element of the classification was scored from 1 to 3. Sexual Dysfunction was defined by a total ≥7, or a score of 3 on any item, or 2 on at least 3 items. Data were entered with Sphinx software version 5.1.0.2 and analyzed with version 18. The comparison of frequencies was done using Pearson's Chi-square test or Fisher's two-tailed exact test according to their applicability conditions with a significance threshold of 0.05. Results: We interviewed 50 patients with cirrhosis during our study period. Sexual dysfunction was observed in 34 patients, 68% of our population. The mean age was 52 years with extremes of 23 and 73 years. An age below 50 years was found in 40% of the patients.In patients with sexual dysfunction, the average age was 53 years with extremes of 35 and 73 years. Of these, 32.4% were younger than 50 years of age. The population was composed of 35 men and 15 women, for a sex ratio of 2.33. Sexual dysfunction was found in 24 men (84%). Active smoking was present in 18 patients. Alcohol abuse was present in 21 patients. Alcohol abuse was present in 21 patients. 95.2% of them had an alcohol abuse (p = 0.0001). Cirrhosis was most often associated with diabetes (13 cases), metabolic syndrome (11 cases) and hypertension (10 cases). In multivariate analysis, only diabetes was significantly associated with sexual dysfonction (p = 0.027). The most common etiologies of cirrhosis were alcohol (25 cases), HBV (15 cases), and NASH (10 cases). Sexual dysfonction was found in 84% of patients with alcoholic cirrhosis, in 80% of patients with postNASH cirrhosis, and 40% of patients with post-HBV cirrhosis. In multivariate analysis, there was a significant association between alcohol and sexual dysfonction (p = 0.015), and between HBV and Sexual dysfonction (p = 0.002). Twenty-nine patients had cirrhosis classified as CHILD A (58% of cases), and 18 patients (36% of cases) had cirrhosis classified as CHILD B. All patients with cirrhosis classified as CHILD C had sexual dysfonction. Sexual dysfonction was significantly related to the severity of the CHILD PUGH score (p = 0.002). Twenty-nine patients had cirrhosis classified as CHILD A (58% of cases), and 18 patients (36% of cases) had cirrhosis classified as CHILD","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology &amp; Digestive Disorders","volume":"252 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121423713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Esophagus Cancer: Epidemiological, Clinical, Para Clinic and Evolving Aspects at Brazzaville Chu 食道癌:流行病学,临床,准临床和发展方面在布拉柴维尔楚
Gastroenterology, Hepatology &amp; Digestive Disorders Pub Date : 2022-06-30 DOI: 10.33425/2639-9334.1062
J. F. Mimiesse, N. A. Itoua-Ngaporo, S. R. Ngami, C. Ahoui-Apendi, A. Mongo-Onkouo, M. Ibobi, Bénédicte Ahombo, Hostaud Atipo Ibara, Lesty Ibara Kolo, Pérès Mordoché Motoula Latou, M. N. Mouakosso, Deby-Gassaye G, B. I. Atipo Ibara
{"title":"Esophagus Cancer: Epidemiological, Clinical, Para Clinic and Evolving Aspects at Brazzaville Chu","authors":"J. F. Mimiesse, N. A. Itoua-Ngaporo, S. R. Ngami, C. Ahoui-Apendi, A. Mongo-Onkouo, M. Ibobi, Bénédicte Ahombo, Hostaud Atipo Ibara, Lesty Ibara Kolo, Pérès Mordoché Motoula Latou, M. N. Mouakosso, Deby-Gassaye G, B. I. Atipo Ibara","doi":"10.33425/2639-9334.1062","DOIUrl":"https://doi.org/10.33425/2639-9334.1062","url":null,"abstract":"Introduction: Our study aimed to describe the epidemiological, clinical, paraclinical and evolutionary aspects of esophageal cancer. Patients and Methods: This is a descriptive retrospective study carried out over 08 years (January 2012 to December 2020) in the gastroenterology and internal medicine department of the Brazzaville University Hospital. We included the files of patients hospitalized for CO retained on a clinical and endoscopic argument bundles. Results: During the study period, 34 cases of esophageal cancer were diagnosed, ie a hospital frequency of 0.63%. The average age was 52.97 years with extremes ranging from 29-90 years. They are made up of 24 men and 10 women with a sex ratio of 2.4 in favor of men. Alcohol-smoking poisoning was found in 21 male patients with an average of 27 packs / year. The main symptom at diagnosis was dysphagia (55.88%). Esogastroduodenal fibroscopy showed ulcerative budding and hemorrhagic lesions (50%), the site of which was mainly the abdominal esophagus (64.70%). Adenocarcinoma was the most common histologic type, 16 patients received palliative care. Conclusion: Esophageal cancer is common in males over the age of 50. Dysphagia is the most frequent reason for consultation. The distal esophagus is the most common site of esophageal cancer and the histologic type is adenocarcinoma. Among our patients, 16 received palliative care.","PeriodicalId":338144,"journal":{"name":"Gastroenterology, Hepatology &amp; Digestive Disorders","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116319979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信